# US 12,005,268 B2 · Ocular light therapy arrangement and method for treating neurological disorders > Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt - Number: US 12,005,268 B2 - Document ID: US12005268B2 - Status: Granted - Kind: B2 - Application number: 17/303,318 - Filed: 2021-05-26 - Published: 2021-12-02 - Granted: 2024-06-11 - Earliest claimed: 2020-05-27 - Assignees: Norb Lighting, LLC. - Applicants: Norb Lighting, LLC. - Inventors: David S. MacKenzie - Web page: https://patentgrep.com/patent/US12005268B2 ## CPC - A61N 5/0622: {Optical stimulation for exciting neural tissue} - A61N 2005/0632: {Constructional aspects of the apparatus} - A61N 2005/0648: {the light being directed to the eyes} - A61N 2005/0651: {Diodes} - A61N 2005/0658: {characterised by the wavelength of light used} - A61N 2005/0662: {Visible light} - A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B) ## Abstract An ocular light therapy arrangement for treating a user having a neurologic disorder includes a light emitting device the emits a light having a flicker rate of less than or equal to about 2 Hz and/or greater than or equal to about 85,000 Hz at a wavelength of within a first range of from about 500 nm to about 565 nm, wherein the light is effective to reduce neurologic disorder symptoms by reducing stimulation of the user's retina and brain cortex. ## Claims ### Claim 1 An ocular light therapy arrangement for treating a user having a neurologic disorder, comprising: a light emitting device that emits a light having a flicker rate of less than or equal to about 2 Hz and/or greater than or equal to about 85,000 Hz only at a first wavelength of within a first range of from about 500 nm to about 565 nm and at a second wavelength of within a second range of from about 800 nm to about 1 mm, such that the light has a targeted perception of flicker to mimic natural light through a canopy of foliage and is effective to reduce neurologic disorder symptoms by reducing stimulation of the user's retina and brain cortex, wherein the light has less than or equal to about 2.5% flicker within the first wavelength range of within the first range of from about 500 nm to about 565 nm. ### Claim 2 (depends on 1) The ocular light therapy arrangement of claim 1, wherein the first range is between 500 nm and 565 nm. ### Claim 3 (depends on 2) The ocular light therapy arrangement of claim 2, wherein the first range is between 510 nm and 550 nm. ### Claim 4 (depends on 3) The ocular light therapy arrangement of claim 3, wherein the wavelength is about 525 nm. ### Claim 5 (depends on 4) The ocular light therapy arrangement of claim 4, wherein the flicker rate is zero Hz. ### Claim 6 (depends on 1) The ocular light therapy arrangement of claim 1, wherein the light emitting device comprises a light emitting diode. ### Claim 7 (depends on 1) The ocular light therapy arrangement of claim 1, wherein the light emitting device is configured to have an output of between about 1 lumen and about 1000 lumen. ### Claim 8 (depends on 7) The ocular light therapy arrangement of claim 7, wherein the output of the light emitting device is variable between about 300 lumen and about 600 lumen. ### Claim 9 (depends on 1) The ocular light therapy arrangement of claim 1, wherein the light emitting device is configured to have an output of greater than or equal to about 600 lumen. ### Claim 10 (depends on 1) The ocular light therapy arrangement of claim 1, further comprising: a base member configured to be releasably received within a light bulb socket; a housing member coupled to the base member; and a diffuser coupled to the base member and cooperating with the base member to define an interior space, wherein the light emitting device is located within the interior space. ### Claim 11 (depends on 1) The ocular light therapy arrangement of claim 1, wherein the second range is between about 710 nm and about 850 nm. ### Claim 12 (depends on 1) The ocular light therapy arrangement of claim 1, wherein the neurologic disorder symptoms include neurologic disorder symptoms of a migraine. ### Claim 13 A method for treating a neurological disorder of a user with an ocular light therapy arrangement, comprising: providing a light emitting device; actuating the light emitting device such that the light emitting device produces a light having a flicker rate of less than or equal to about 2 Hz and/or greater than or equal to about 85,000 Hz only at a first wavelength of within a first range of from about 500 nm to about 565 nm and at a second wavelength of within a second wavelength range of from about 800 nm to about 1 mm, wherein the light has less than or equal to about 2.5% flicker within the first wavelength range of within the first range of from about 500 nm to about 565 nm, such that the light has a targeted perception of flicker to mimic natural light through a canopy of foliage; and positioning the light emitting device such that the light emitted from the light emitting device illuminates a space occupied by the user, wherein the light is effective to reduce neurologic disorder symptoms by reducing stimulation of the user's retina and brain cortex. ### Claim 14 (depends on 13) The method of claim 13, where the first range is between 500 nm and 565 nm. ### Claim 15 (depends on 13) The method of claim 13, wherein the flicker rate is less than or equal to about 1 Hz. ### Claim 16 (depends on 13) The method of claim 13, wherein this second range is between about 710 nm and 850 nm. ### Claim 17 An ocular light therapy arrangement for treating a user having a neurologic disorder, comprising: a light emitting device that emits a light having a flicker index of less than or equal to about 1.0 at a first wavelength of within a first range of from about 500 nm to about 565 nm and at a second wavelength of within a second range of from about 800 nm to about 1 mm, such that the light has a targeted perception of flicker to mimic natural light through a canopy of foliage and is effective to reduce neurologic disorder symptoms by reducing stimulation of the user's retina and brain cortex, wherein the light has less than or equal to about 2.5% flicker within the first wavelength range of within the first range of from about 500 nm to about 565 nm. ### Claim 18 (depends on 17) The ocular light therapy arrangement of claim 17, wherein the light has a flicker rate of less than or equal to about 2 Hz within the wavelength range of from about 500 nm to about 565 nm. ### Claim 19 (depends on 17) The ocular light therapy arrangement of claim 17, wherein the light emitting device only emits the light with a wavelength range of between about 480 nm and about 600 nm. ### Claim 20 (depends on 17) The ocular light therapy arrangement of claim 17, wherein the light emitting device is configured to have an output of between about 300 lumen and about 600 lumen. ### Claim 21 (depends on 19) The ocular light therapy arrangement of claim 19, further comprising: a base member configured to be releasably received within a light bulb socket; a housing member coupled to the base member; and a diffuser coupled to the base member and cooperating with the base member to define an interior space, wherein the light emitting device is located within the interior space.